Author(s): Cramer RD
Abstract Share this page
Abstract QSAR approaches, including recent advances in 3D-QSAR, are advantageous during the lead optimization phase of drug discovery and complementary with bioinformatics and growing data accessibility. Hints for future QSAR practitioners are also offered.
This article was published in J Comput Aided Mol Des
and referenced in Journal of Molecular and Genetic Medicine